FloridaTaper
Evidence-based information on benzodiazepine tapering, withdrawal, and BIND
FloridaTaper publishes careful, evidence-informed writing on benzodiazepine tapering, withdrawal, and recovery — for patients, families, and clinicians.
Browse by topic
Latest articles
-
Akathisia During Benzodiazepine Withdrawal: The Restlessness Nobody Warns You About
Akathisia is one of the most distressing experiences a person can have, and one of the least understood by clinicians who have not seen it in benzodiazepine patients. The word itself comes…
-
What Is the Ideal Cut Percentage? Finding the Sweet Spot in Benzodiazepine Tapering
The most common question patients ask once they decide to taper a benzodiazepine is also one of the hardest to answer: how much should each cut be? A patient who reads the…
-
Why the Ashton Manual Crossover Fails for Some Patients, and What to Do When Diazepam Provides No Relief
The Ashton Manual is the foundational text on benzodiazepine tapering, and the crossover from a short-acting benzodiazepine to diazepam is one of its most influential recommendations. The logic is sound. Diazepam has…
-
Hydroxyzine vs Promethazine: Which Works Better for BIND Symptoms, and Which Is Safer?
When patients move through a benzodiazepine taper or live with Benzodiazepine-Induced Neurological Dysfunction (BIND), the search for symptom relief turns up two medications more often than most others: hydroxyzine and promethazine. Both…
-
Temperature Dysregulation in Benzodiazepine Withdrawal: When Hot Flashes Are Not Hormonal
Hot flashes, heat intolerance, and episodes of flushing and sweating during benzodiazepine withdrawal are frequently misattributed to menopause, thyroid dysfunction, or anxiety. The symptom overlap is real and the misattribution is common.…
-
Mast Cell Activation Syndrome and BIND: Neuroimmune Overlap or Separate Disease?
Patients with benzodiazepine-induced neurological dysfunction (BIND) and patients with mast cell activation syndrome (MCAS) frequently describe overlapping symptom profiles: flushing, GI dysfunction, palpitations, sensory hypersensitivity, new food and medication reactions, sleep disruption,…
-
Gastroparesis in Benzodiazepine Withdrawal: Vagus Nerve Dysfunction as the Missing Link
Gastroparesis — delayed gastric emptying in the absence of mechanical obstruction — is reported by a meaningful minority of patients in protracted benzodiazepine withdrawal and in benzodiazepine-induced neurological dysfunction (BIND). The symptoms…
-
Lyme Disease Workups in Protracted Benzodiazepine Withdrawal: What the Clinical Overlap Actually Looks Like
Patients in protracted benzodiazepine withdrawal frequently encounter a Lyme disease workup somewhere along their diagnostic odyssey. The reasons are understandable. The symptom overlap is real: fatigue, cognitive dysfunction, paresthesias, autonomic instability, muscle…
-
IBS Symptoms During a Benzodiazepine Taper: How GABA in the Enteric Nervous System Explains It
New-onset irritable bowel syndrome (IBS) symptoms during a benzodiazepine taper are a recognizable clinical pattern. Abdominal pain, cramping, bloating, and altered bowel habits — usually diarrhea, sometimes constipation, frequently alternating — emerge…
-
Fibromyalgia or BIND? A Diagnostic Collision Patients Keep Running Into
A patient with chronic widespread pain, fatigue, sleep disturbance, and cognitive symptoms can reasonably meet criteria for fibromyalgia. The same patient, if they have a history of long-term benzodiazepine use with a…